Sci Show: Pfizer's COVID-19 RNA vaccine shows "robust" results in phase 1/2 trial published in Nature today. BNT162b1 "elicited a robust immune response in participants, which increased with dose level and with a second dose."

Wednesday, August 12, 2020

Pfizer's COVID-19 RNA vaccine shows "robust" results in phase 1/2 trial published in Nature today. BNT162b1 "elicited a robust immune response in participants, which increased with dose level and with a second dose."

https://ift.tt/33QRYSF via /r/science https://ift.tt/3izu1Dn

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)